ロード中...
Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds
Antigenicity remains the primary barrier towards expanding the use of unfixed xenogeneic biomaterials in clinical applications. An unfixed xenogeneic biomaterial devoid of antigenicity, with maintained structural and mechanical integrity, has potential to overcome the limitations of current clinical...
保存先:
| 出版年: | Acta Biomater |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6349227/ https://ncbi.nlm.nih.gov/pubmed/30130615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.actbio.2018.08.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|